Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
+10.6%/yr
vs +30.8%/yr prior
5Y CAGR
+14.2%/yr
Recent deceleration
Acceleration
-20.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $12.07B | +9.6% |
| 2024 | $11.02B | +11.7% |
| 2023 | $9.87B | +10.5% |
| 2022 | $8.93B | +17.9% |
| 2021 | $7.57B | +22.1% |
| 2020 | $6.21B | +49.1% |
| 2019 | $4.16B | +36.6% |
| 2018 | $3.05B | +22.5% |
| 2017 | $2.49B | +46.2% |
| 2016 | $1.70B | - |